Model
Edge
Janux Therapeutics
0001864159
Filing Type
4
Filing Date
5/1/2025
Updated
5/2/25, 6:00 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership